South African pharmaceutical firm iNova has acquired the Flugon brand from Tara Pharmaceuticals and will re-release the entire range with new packaging in April.

Flugon is one of South Africa’s most well-known colds, flu and allergy treatment ranges.

iNova Pharmaceuticals has acquired the Flugon brand from Tara Pharmaceuticals. This acquisition took place in June last year and iNova has worked on revived new packaging which will be available on shelf at leading pharmacies nationwide from April.

The extensive Flugon range, which includes a colds, flu and allergy range as well as a symptomatic relief range, fits perfectly within iNova’s extensive and growing Lifestyle Portfolio. The numerous benefits of the various products within the Flugon Natural Colds, Flu and Allergy ranges includes building the immune system, helping to fight cold and flu infections and providing allergy relief.

The Colds, Flu and Allergy range contain ingredients such as Beta-carotene, Citrus bioflavonoids, Vitamin C and Zinc for their antioxidant properties as well as Pelargonium, Echinachea and Elderberry extract for their antiviral properties.

This Colds, Flu and Allergy range includes capsules, fizzies and a colds and flu syrup, all suitable for ages 12 years and older. Grape flavoured Flugon Fizzy Kidz is available for children over the age of 4.

The Symptomatic Relief range includes a cough syrup, hot lemon, throat spray and vapobalm, also containing natural ingredients which include Menthol, Eucalyptus and Tea Tree.

For more information go to